FDA approves new Alzheimer’s blood test that family doctors can order
FDA approves new Alzheimer’s blood test for people over 55. Here’s what it can — and can’t —…
PBS dispute could leave MS patients with huge bills for crucial drugs Ocrevus and Kesimpta
A dispute over how Australia prices medicines has sparked fears 10,000 people with multiple sclerosis will be forced…
Global drug makers face pricing pressure as China targets affordable healthcare
Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial – Endpoints News
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial Endpoints NewsRoche unveils data behind BTK inhibitor’s phase 3…
Shanghai to scrap all foreign investment limits on manufacturing facilities
Mainland China’s commercial and financial hub Shanghai has pledged to remove all regulatory hurdles for foreign investors to…